This article has been updated to include a comment from Perlegen's CEO.

NEW YORK (GenomeWeb News) – Perlegen Sciences, the privately held, Mountain View, Calif.-based pharmacogenomics and genotyping services firm, has ceased operations as of Oct. 30, 2009.

The firm's website has little information remaining on it, but lists as its current contact RoseRyan Inc., a Silicon Valley consulting firm, which a person familiar with the situation said is helping Perlegen close its operations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.